Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CYP4A11 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CGB1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
SLC9A5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DPY19L1P1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PAX9 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PTGER1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PITX3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
POMC - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
XPO6 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SPATA5L1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SCAND2P - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HTATIP2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MMP23A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HTRA1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CYP3A43 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FBXO16 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IGF1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FGFR2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
INPP5K - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DLGAP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on